{
    "organizations": [],
    "uuid": "825faf9f3f0f1e708bf4056bb4e2c95a0b499a16",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-prevail-therapeutics-announces-75/brief-prevail-therapeutics-announces-75-mln-series-a-financing-idUSASB0C9EA",
    "ord_in_thread": 0,
    "title": "BRIEF-Prevail Therapeutics Announces $75 Mln Series A Financing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) -\n* PREVAIL THERAPEUTICS ANNOUNCES $75 MILLION SERIES A FINANCING TO ADVANCE GENE THERAPIES FOR PATIENTS WITH PARKINSONâ€™S AND OTHER NEURODEGENERATIVE DISEASES\n* PREVAIL THERAPEUTICS, A BIOTECHNOLOGY COMPANY, SAYS ANNOUNCED A $75 MILLION SERIES A FINANCING Source text for Eikon:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T20:17:00.000+02:00",
    "crawled": "2018-03-09T14:36:19.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "prevail",
        "therapeutic",
        "announces",
        "million",
        "series",
        "financing",
        "advance",
        "gene",
        "therapy",
        "patient",
        "parkinson",
        "neurodegenerative",
        "disease",
        "prevail",
        "therapeutic",
        "biotechnology",
        "company",
        "say",
        "announced",
        "million",
        "series",
        "financing",
        "source",
        "text",
        "eikon",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}